维普中文期刊产品整合服务
14341篇 您的检索式:作者名="SHEN Y"
    题名 作者 年代 出处 被引量
1Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non-Small-Cell Lung Cancer(摘要)显示文摘Hu, ZB Chen, X Zhao, Y Tian, T Jin, GF Shu, YQ Chen, YJ Xu, L Zen, K Zhang, CY Shen, HB 2010南京医科大学学报(自然科学版)2010,30,7:141
2慢性阻塞性肺疾病加重期间肠道和肺部微生物的动态变化显示文摘肠道-肺微生态系统紊乱和调节障碍在慢性阻塞性肺疾病(COPD)恶化过程中发挥关键性作用然而,COPD急性加重期肠道-肺菌群的动态变化及其在疾病病因学中的潜在作用仍知之甚少。研究者为了解慢性阻塞性肺疾病急性加重期(AECOPD)肠道和肺部微生物的动态变化,在15例AECOPD患者急性发作第1、7天和第4天纵向收集90份标本(痰液和粪便标本各45份)。Sun Z Zhu QL Shen Y 曾雪涛(编译) 2020中华医学杂志2020,100,40:23
3Polymorphisms of MTHFD,plasma homocysteine levels, and risk of gastric cancer in ahigh-risk Chinese population显示文摘Purpose:Accumulative evidence suggests that folate has a protective effect on gastric cancer. The methylenetetrahyd-rofolate dlehydrogenase(MTHFD) plays an important role in folate and homocysteine metabolisms, and polymorphisms of MTHFD may result in disturbance of the folate-mediated homocysteine pathway. The aim of this study is to test the hypothesis that genetic variants of MTHFD and plasma homocysteine levels are associated with risk of gastric cancer and modulated by genotypes of methylenetetrahydrofolate reductase(MTHFR). Experimental Design: We genotyped G1958A and T401C in MTHFD and C677T in MTHFR and detected total plasma homocysteine(tHcy) levels in a case-control study of 589 gastric cancer cases and 635 cancer-free controls in a high-risk Chinese population. Results:The variant genotypes of MTHFD 1958AA and 401CC were associated with a significantly increased risk of gastric canceradjusted odds ratio(OR), 2.05; 95% confidence interval(95% CI),1.34-3.13 for 1958AA; adjusted OR,1.43; 95% CI,1.14-1.80 for 401CC compared with 1958GG/GA and 401TT/TC genotypes, respectively. Both of the effects were more evident in the subjects carrying MTHFR 677CT/TT genotypes. The average tHcy level was significantly higher in gastric cancer cases than in controls(P < 0.01), and the upper quartile of tHcy (> 13.6 mu mol/L) was associated with an 82% significantly increased risk of gastric cancer, compared with the lowest quartile of tHcy(<= 8.0 pmol/L;adjusted OR,1.82; 95% CI,1.20-2.75). Conclusions:The strong associations between MTHFD variants and the plasma tHcy levels and gastric cancer risk suggest, for the first time, a possible gene-environment interaction between genetic variants of folate-metabolizing genes and high tHcy levels in gastric carcinogenesis.Wang, L. N Ke, Q Chen, W. S Wang, J. M Tan, Y. F Zhou, Y Hua, Z. L Ding, W. L Niu, J. Y Shen, J Zhang, Z. F Wang, X. R Xu, Y. H Shen, H. B Yi Xing 2007南京医科大学学报(自然科学版)2007,27,7:10
4Renal cell carcinoma: Evolving and emerging subtypes显示文摘Our knowledge of renal cell carcinoma(RCC) is rapidly expanding. For those who diagnose and treat RCC, it is important to understand the new developments. In recent years, many new renal tumors have been described and defined, and our understanding of the biology and clinical correlates of these tumors is changing. Evolving concepts in Xp11 translocation carcinoma, mucinous tubular and spindle cell carcinoma, multilocular cystic clear cell RCC, and carcinoma associated with neuroblastoma are addressed within this review. Tubulocystic carcinoma, thyroid-like follicular carcinoma of kidney, acquired cystic disease-associated RCC, and clear cell papillary RCC are also described. Finally, candidate entities, including RCC with t(6;11) translocation, hybrid oncocytoma/chromophobe RCC, hereditary leiomyomatosis and RCC syndrome, and renal angiomyoadenomatous tumor are reviewed. Knowledge of these new entities is important for diagnosis, treatment and subsequent prognosis. This review provides a targeted summary of new developments in RCC.Suzanne M Crumley Mukul Divatia Luan Truong Steven Shen Alberto G Ayala Jae Y Ro 2013World Journal of Clinical Cases2013,1,9:7
5中国成人糖尿病、血糖与结直肠癌发病率:针对50万人的前瞻性研究显示文摘背景糖尿病可致结直肠癌(CRC)的发病风险升高。糖尿病病程和非糖尿病患者的血糖与CRC发病风险之间的相关性仍不清楚。方法2004至2008年前瞻性中国Kadoofe Biobank研究从10个不同地区纳入了512 713名受试者。在10年随访期间,在基线无癌症史的510 136名受试者中共记录有3 024例新发CRC病例(1 745例结肠癌,1 716例直肠癌)。应用Cox回归分析对糖尿病(入组前诊断或筛查发现的)或无糖尿病病史者随机血糖(RPG)水平与CRC发病相关性的校正风险比(HR)进行估计。结果基线时,共有5.8%的受试者患有糖尿病。糖尿病患者发生CRC的校正HR为1.18(95%可信区间1.04~1.33),且发生结肠癌与直肠癌的风险相当[1.19(1.01~1.39)比1.14(0.96~1135)]。这些患者发生CRC的HR随糖尿病病程的延长而下降(趋势P值为0.03)。在入组前无糖尿病的受试者中,其RPG水平与CRC发病呈正相关,基线RPG每升高1 mmol/L其发生CRC的校正HR为1.04(1.02~1.05),且发生结肠癌与直肠癌的风险亦相当[1.03(1.01~1.05)比1.04(1.02~1.06)]。在男性中,糖尿病和RPG与CRC发病风险的相关性高于女性,但其差异无统计学意义(异质性检验的P值分别为0.3和0.2)。讨论在中国成年人中,未诊断糖尿病者其糖尿病和升高的血糖水平与CRC发病风险升高相关。Yuanjie Pang Christiana Kartsonak yu Guo Yiping Chen Ling Yang Zheng Bian Fiona Bragg Iona Y Millwood Leijia Shen Songgen Zhou Jiben Liu Junshi Chen Liming Li Michael V Holmes Zhengming Ghen 霍永丰(译) 2019英国医学杂志中文版2019,22,1:6
6Mutation analysis of autosomal dominant polycystic kidney disease genes in Han Chinese显示文摘Zhang S Mei C Zhang D Dai B Tang B Sun T Zhao H Zhou Y Li L Wu Y Wang W Shen X Song J 2005第二军医大学学报2005,26,8:6
7Internal Oxidation of Cu-Al Alloy显示文摘Wu, JJ Zhang, Y Shen, YT Li, GB Lei, TQ 1999Journal of Materials Science & Technology1999,15,5:5
8Regulation of Nrf2- and AP-l-mediated gene expression by epigallocatechin-3-gallate and sulforaphane in prostate of Nrf2-knockout or C57BL/6J mice and PC-3 AP-1 human prostate cancer cells显示文摘Sujit NAIR Avantika BARVE Tin-Oo KHOR Guo-xiang SHEN Wen LIN Jefferson Y CHAN Li CAI Ah-Ng KONG 2010Acta Pharmacologica Sinica2010,31,9:5
9恩替卡韦诱导的干扰素λ1对乙型肝炎肝硬化患者Ⅱ型固有淋巴细胞的抑制作用显示文摘[据Journal of Viral Hepatitis 2021年5月报道]题:恩替卡韦诱导的干扰素λ1对乙型肝炎肝硬化患者Ⅱ型固有淋巴细胞的抑制作用(作者Wang SQ等)已有研究证实,恩替卡韦在抗HBV过程中发挥着免疫调节作用。本研究旨在确定在HBV相关肝病进程中,恩替卡韦对非自然杀伤固有淋巴细胞(non-NK ILCs)的影响。王思奇 蒋炜 WANG SQ SHEN Y LI J 2021临床肝胆病杂志2021,37,7:4
10JWA regulates melanoma metastasis by integrin alpha(V)beta(3) signaling(摘要)显示文摘Bai, J Zhang, J Wu, J Shen, L Zeng, J Ding, J Wu, Y Gong, Z Li, A Xu, S Zhou, J Li, G 2010南京医科大学学报(自然科学版)2010,30,8:4
11Isolation and characterization of neural stem cells from human fetal striatum显示文摘Li X Xu J Bai Y Wang X Dai X Liu Y Zhang J Zou J Shen L Li L 2006中国生物学文摘2006,20,5:3
12基于工作地点的分组干预对高血压控制的影响:一项随机临床研究显示文摘基于工作地点的干预可能为一种管理高血压的有效方法。但是目前缺少针对中国工作人群高血压控制情况的研究。本研究旨在评估基于工作地点的多组分别干预策略对改善血压控制的影响。研究设计及受试者:研究者在2013年1月至2014年12月于中国20个城区的60个工作地点进行了一系列高血压管理的随机临床试验。工作地点随机分为干预组(n=40)和对照组(n=20)。每个工作地点的受试者都需要完成一项横断面调查。袁源(摘译) 叶鹏(审校) Wang Z Wang X Shen Y Li S Chen Z Zheng C Kang Y Jiang L Hao G Chang C Gao R 2020中华高血压杂志2020,28,6:3
13美国地震学会通报(BSSA)2008年四川汶川地震专集介绍显示文摘Klinger Y Ji C Shen Z-K Bakun W H 李平恩(译) 左玉玲(校) 2010国际地震动态2010,,12:3
14中国人群癫痫相关胶质神经元肿瘤中BRAF V600E突变的检测及临床意义显示文摘背景胶质神经元肿瘤(Glioneuronal tumors,GNTs)包含神经节神经胶质瘤(Gangliogliomas,GGs)和胚胎发育不良性神经上皮瘤(Dysembryoplastic neuroepithelial tumors,DNTs),是最常见的组织学类型,常位于大脑皮层,相关症状常于早期表现出来,其中癫痫是最突出且常常是唯一神经系统症状。丁美萍 Zhang YX Shen CH Guo Y 2017癫痫杂志2017,3,1:3
15Common non-synonymous polymorphisms in the BRCA1 Associated RING Domain (BARD1) gene are associated with breast cancer susceptibility:a case-control analysis显示文摘The BRCA1 Associated RING Domain(BARD1) gene has been identified as a high penetrance gene for breast cancer, whose germline and somatic mutations were reported in both non-BRCA1/2 hereditary site-specific and sporadic breast cancer cases. BARD1 plays a crucial role in tumor repression, along with its heterodimeric partner BRCA1. In the current study, we tested the hypothesis that common non-synonymous polymorphisms in BARD1 are associated with breast cancer susceptibility in a case-control study of 507 patients with incident breast cancer and 539 frequency-matched cancer-free controls in Chinese women. We genotyped all three common(minor allele frequency (MAF) > 0.10) non-synonymous polymorphisms(Pro24Ser, Arg378Ser, and Val507Met) in BARD1. We found that the BARD1 Pro24Ser variant genotypes(24Pro/Ser and 24Ser/Ser) and Arg378Ser variant homozygote 378Ser/Ser were associated with a significantly decreased breast cancer risk, compared with their wild-type homozygotes, respectively. Furthermore, a significant locus-locus interaction was evident between Pro24Ser and Arg378Ser (P-int = 0.032). Among the 378Ser variant allele carriers, the 24Pro/Pro wild-type homozygote was associated with a significantly increased breast cancer risk (adjusted OR = 1.81, 95% CI = 1.11-2.95), but the subjects having 24Pro/Ser or Ser/Ser variant genotypes had a significantly decreased risk(adjusted OR = 0.74, 95% CI = 0.56-0.99). In stratified analysis, this locus-locus interaction was more evident among subjects without family cancer history, those with positive estrogen receptor (ER) and individuals with negative progesterone receptor(PR). These findings indicate that the potentially functional polymorphisms Pro24Ser and Arg378Ser in BARD1 may jointly contribute to the susceptibility of breast cancer.Huo, X Hu, Z. B Zhai, X. J Wang, Y Wang, S Wang, X. C Qin, J. W Chen, W. S Jin, G. F Liu, J. Y Gao, J Wei, Q. Y Wang, X. R Shen, H. B 2007南京医科大学学报(自然科学版)2007,27,7:3
163D-QSAR STUDY ON HUPERZINE A ANALOGS WITH MOLECULAR MODELING AND COMPARATIVE MOLECULAR FIELD ANALYSIS(COMFA) METHODS显示文摘3D-QSARSTUDYONHUPERZINEAANALOGSWITHMOLECULARMODELINGANDCOMPARATIVEMOLECULARFIELDANALYSIS(COMFA)METHODS¥HuaLiangJIANG;KaiXianC...Jiang, HL Chen, KX Chen, JZ Tang, Y Wang, QM Li, Q Shen, X Ji, RY 1996Chinese Chemical Letters1996,7,3:2
17The general solution of three-dimensional problems in magnetoelectroelastic media 显示文摘WANG X SHEN Y P 2002Int J Eng Sci2002,40,10:2
18Schisandrin B enhances doxorubicin-induced apoptosis of cancer cells but not normal cells显示文摘Li L Lu Q Shen Y 0,,:2
19二硫戊环衍生物和类似物的合成及其iNOS/PAF双重抑制剂活性(英文)显示文摘目的 :研究双重作用的新型抗炎药物。方法 :合成二硫戊环衍生物和类似物 ,研究这些化合物及选择性的PAF受体拮抗剂L6 5 9,989对PAF受体的结合 ,和对IFN γ或LPS诱导的NO生成 ,以及对iNOSmRNA表达的影响。结果 :合成了 4 0个新化合物 ,其中 19个在不同程度上抑制NO生成。选择 3个活性最高的化合物 (2 ,19,2 0 )进行深入研究 ,发现它们能抑制iNOSmRNA的表达 ,其抑制NO生成的效力从高到低依次为 :19,2 0 ,2 ,L6 5 9,989,其拮抗PAF受体的活性从高到低依次为 :L6 5 9,989,2 0 ,2 ,19。L6 5 9,989对NO生成和iNOSmRNA表达无影响。受试物的PAF受体拮抗活性与iNOS抑制活性之间无简单关联。结论 :二硫戊环类化合物是iNOS表达的新型调控剂 ,其中一些具有抑制iNOS的诱导和拮抗PAF受体的双重活性。张奕华 HUSSAINI Isa M SHEN Tsung Y 2003中国药科大学学报2003,34,3:2
20Geometric phase in spin precession and the adiabatic approximation 显示文摘Ni G J Chen S Q Shen Y L 1995Phys Lett1995,197,:2
返回顶部 每页显示:
共718页 首页 上一页 第1页 下一页 末页 /718 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费